Our statute and by-laws

If you wish to download the documents, please click on the links below:


Governance 

Current EAMBES Governance and  the past Executives of EAMBES.
 

Tweets by EAMBES.org

EAMBES News

On 16 September 2014, a debate was held in the European Parliament on structural funding for Horizon 2020 during which new budgetary issues were highlighted. The Commission will see a shortfall of 40% of funding commitments to researchers which could lead to the Commission failing to make good on their contractual arrangements and putting many research projects under threat.

[Read the rest of this article...]


On 10 September 2014 together with the announcement of a change in Commission portfolios, came President of the Commission, Jean-Claude Junker’s list of Commissioners-designate.

[Read the rest of this article...]


On 10 September 2014, President of the European Commission Jean Claude Juncker announced a reorganisation of certain key portfolios.

[Read the rest of this article...]


On the 16 September 2014, the European Commission presented the ERA progress report. It shows that the ERA partnership between Member States, research stakeholders and the Commission has made good progress in delivering European Research Area (ERA), and that the conditions for achieving it identified in 2012 (see the Commission’s Communication - A Reinforced European Research Area Partnership for Excellence and Growth) are in place at the European level.

[Read the rest of this article...]


The hearings of the Dr. Vytenis Andrukaitis, Commissioner Designate for Health and Food Safety took place in the Environment, Public Health and Food Safety (ENVI) today the 30 September 2014. MEP questions and the atmosphere of the debate was largely non-confrontational, indicating a likely endorsement for the candidate. It is interesting to note that Dr. Andriukaitis seemed markedly more confident on human health matters, showing both his professional background and his political experience. His answers on what is now the majority of his portfolio, regarding food safety and animal matters, tended to be more often vague.

[Read the rest of this article...]


IMI 2 will hold an Open Info Day on its IMI 2-Call 1 in Brussels, Belgium on Tuesday 30 September 2014. The deadline for registration is the 23 September 2014.

[Read the rest of this article...]


On behalf of the President of EAMBES, Prof. Birgit Glasmacher, we hereby cordially invite you to attend the next GC and GA Meeting, organized during the 48th DGBMT Annual Conference (within VDE) in Hannover, Germany (www.bmt2014.de).

[Read the rest of this article...]


 Deadline for this call is extended to October 15th

[Read the rest of this article...]


 Just a quick reminder that the NBC16/MTD10 in Goteborg is approaching.

[Read the rest of this article...]


On her website on 17 September 2014, Mrs. Willmott stated that “we must ensure the industry is transparent and works in the interest of patients. This legislation will go a long way to achieving that and I look forward to taking it further in the coming months” She also expressed concern that the responsibility for medical devices policy will not fall under the auspices of DG Enterprise, following a decision by Mr. Junker which is being increasingly criticized by key EU stakeholders. As rapporteur for the Clinical Trials Regulation and a long-standing health-focused MEP, Mrs. Willmott was one of three main MEPs tipped to be the next Rapporteur of the MDR who will take over from ousted MEP Ms. Dagmar Roth-Behrendt (S&D, Germany). The other two potential MEPs that were suggested were Ms. Linda McAvan (S&D, UK) and Ms. Christel Schaldemose (S&D, Denmark). While Ms. Willmott did not take a central role in the discussions on the Medical Devices Regulation during the previous Parliamentary term, her focus during the Clinical Trials Regulation was on improving transparency and safety for patients.

[Read the rest of this article...]


Page 6 of 25First   Previous   1  2  3  4  5  [6]  7  8  9  10  Next   Last